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Abstract
Vaccination of one person may prevent the infection of another either because
(i) the vaccine prevents the first from being infected and from infecting the sec-
ond or because (ii) even if the first person is infected, the vaccine may render the
infection less infectious. We might refer to the first of these mechanisms as a
contagion effect and the second as an infectiousness effect. In this paper, for the
simple setting of a randomized vaccine trial with households of size two, we use
counterfactual theory under interference to provide formal definitions of a con-
tagion effect and an infectiousness effect. Using ideas analogous to mediation
analysis, we show that the indirect effect (the effect of one individual’s vaccine on
another’s outcome) can be decomposed into a contagion effect and an infectious-
ness effect on the risk difference, risk ratio, odds ratio and vaccine efficacy scales.
We provide identification assumptions for such contagion and infectiousness ef-
fects, and describe a simple statistical techniques to estimate these effects when
they are identified. We also give a sensitivity analysis techniques to assess how
inferences would change under violations of the identification assumptions. The
concepts and results of this paper are illustrated with sample vaccine trial data.
Introduction
Administering a vaccine to one or several individuals in a population may
protect not only those vaccinated individuals from infection or disease, but
also other individuals as well. In the causal inference vaccine literature, the
protection a¤orded other unvaccinated individuals has been called the indirect
e¤ects of vaccination. A number of papers have considered the methodology of
estimating such indirect e¤ects.1 5 With an indirect e¤ect, we might conceive
of two distinct mechanisms by which such an e¤ect may operate. Suppose we
have two persons in a household and that we vaccinate the rst. Vaccinating
the rst person may protect the second by preventing the infection in the rst
and thereby preventing the infection from spreading from the rst person to
the second. Alternatively, vaccinating the rst person may protect the second
because, even if the rst person is infected the vaccine may render the infection
less infectious, thereby preventing the rst person from infecting the second.
This latter e¤ect is sometimes referred to as an "infectiousness e¤ect".3;6;7
We will refer to the former as a "contagion e¤ect", following terminology in
the social network literature8;9, though we acknowledge that "infectiousness"
and "contagion" are sometimes used interchangeably in the infectious disease
literature.
In this paper we show that in households of size two, the indirect e¤ect
can be decomposed into a contagion e¤ect and an infectiousness e¤ect. We
draw on theory for causal inference under interference4;7;10;11 and on mediation
analysis12 15 to provide formal counterfactual decompositions for each of these
e¤ects. We show that decompositions of the indirect e¤ect into a contagion
and infectiousness e¤ect hold for the risk di¤erence, risk ratio, odds ratio and
vaccine e¢ cacy scales. We discuss identication assumptions that su¢ ce to
estimate these e¤ects from vaccine trial data and propose a simple statistical
modeling strategy using logistic regressions to estimate these e¤ects. We also
describe a sensitivity analysis technique for these e¤ects that can be employed
when the identication assumptions do not hold to assess the sensitivity of
the estimates to violations in the assumptions being made. We illustrate the
methodology with application some sample vaccine trial data.
Concepts and Denitions
We consider a setting similar to that in VanderWeele and Tchetgen Tchetgen7
in which there are N households indexed by i = 1; :::; N such that each house-
hold consists of two persons indexed by j = 1; 2. We will generalize this
setting somewhat in the nal section of the paper. We let Aij denote the vac-
cine status for individual j in household i. We let Aij = 1 denote that the
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person j in household i was vaccinated and let Aij = 0 denote that the per-
son was not vaccinated. We let Yij denote the infection status of individual j
in household i after some xed follow up period. We let Yij(ai1; ai2) denote
the counterfactual outcome for person j in household i if the two persons in
that household had, possibly contrary to fact, vaccination status of (ai1; ai2).
For example, Yi2(1; 0) would denote what would have happened to person 2 if
person 1 had received the vaccine and person 2 had not; and Yi1(0; 0) denotes
what would have happened to person 1 if neither person 1 nor person 2 had
received the vaccine. Note that under this counterfactual or "potential out-
comes" notation, the potential outcome for individual 1, Yi1(ai1; ai2) depends
on the vaccine status of both person 1 and person 2, and likewise the potential
outcome for individual 2, Yi2(ai1; ai2) depends on the vaccine status of both
persons. This allows for the possibility that the exposure status of one person
a¤ects the outcome of another. In the statistics literature, this is sometimes
referred to as interference or spillover e¤ect.4;10;16 19
Most literature in causal inference makes a "no interference" assumption16;20
that one persons outcome does not depend on the exposure of others. In the
current context this would imply that Yi1(ai1; ai2) = Yi1(ai1) and Yi2(ai1; ai2) =
Yi2(ai2) so that each persons outcome depends only on his or her own exposure
status. This type of no-interference assumption is implausible in the infec-
tious disease context, and so we do not make it here. We do, however, assume
that the exposure status of persons in one household in the study do not a¤ect
the outcomes of those in other study households; this is sometimes referred
to as an assumption of partial inference.10;17 This might be plausible if the
various households are su¢ ciently geographically separated or do not interact
with one another. Throughout this paper we will assume a simple randomized
experiment in which one of the two persons is randomized to receive a vaccine
or control and the second person is always unvaccinated. However, we note in
the Discussion section, that a similar analysis would be applicable if the second
person were always vaccinated, or in a trial in which the second person were
randomized to vaccination and the clusters in which the second person were
and were not vaccinated were analyzed separately. In the Discussion section,
we also briey consider settings with multiple people per household. We will
let j = 1 denote the individual who may or may not be vaccinated and j = 2
the individual who is always unvaccinated.
Using this counterfactual notation, the average indirect e¤ect would then
simply be
E[Yi2(1; 0)  Yi2(0; 0)]
i.e. the di¤erence in infection status for person 2 if person 1 is vaccinated versus
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unvaccinated.10 If vaccine status is randomized then this can be estimated
simply by3;7:
E[Yi2jAi1 = 1; Ai2 = 0]  E[Yi2jAi1 = 0; Ai2 = 0]:
Halloran and Hudgens3 also refer to this as the "ITT (intention to treat)
indirect e¤ect."
To proceed with decomposing this indirect e¤ect into a contagion e¤ect and
an infectiousness e¤ect we need also to consider counterfactuals of a di¤erent
form. From this point onwards, we assume that only person 1, not person
2, can be infected from outside the household; person 2 can only be infected
by person 1. Thus if Yi1(ai1; ai2) = 0 then Yi2(ai1; ai2) = 0. This might be
a plausible assumption if person 2 were an infant or a home-bound elderly
person. The assumption would also be plausible in certain case-control study
designs of rare or acute infections in which it is highly unlikely that both
persons are infected from outside the household, but this setting would require
further development. Suppose then that in addition to potentially intervening
to give person 1 the vaccine we could also, at least hypothetically, consider
intervening to give or prevent the infections in person 1. We could then let
Yi2(ai1; ai2; yi1) denote the infection status of person 2 if we had intervened,
possibly contrary to fact, to set the vaccine status of person 1 and person 2
to ai1 and ai2 respectively and the infection status of person 1 to yi1. This in
some sense formalizes, using counterfactual notation, ideas that were proposed
by Halloran and Struchiner.2
Because, throughout the paper, we assume that individual 2 is always
unvaccinated, we can somewhat simplify the notation above. The counterfac-
tuals Yi1(ai1; ai2) and Yi2(ai1; ai2), we can write as Yi1(ai1) := Yi1(ai1; 0) and
Yi2(ai1) := Yi2(ai1; 0). Note that we are still assuming interference/spillover in
that the vaccine of individual 1 a¤ects the outcome of person 2. Likewise the
vaccine status of person 2 would a¤ect the outcome of person 1 but in this
simple randomized experiment, person 2 always remains unvaccinated. This
simple setting in which person 2 always remains unvaccinated also allows us
to rewrite the counterfactual Yi2(ai1; ai2; yi1) as Yi2(ai1; yi1) := Yi2(ai1; 0; yi1).
We thus will be considering counterfactuals of the form Yi1(ai1), Yi2(ai1) and
Yi2(ai1; yi1). The direct e¤ect of the person 1s vaccine on person 1s outcome
is E[Yi1(1)  Yi1(0)]; the indirect e¤ect of the person 1s vaccine on person 2s
outcome is simply E[Yi2(1)   Yi2(0)]. In the next section we will use these
counterfactuals to dene contagion and infectiousness e¤ects.
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Contagion and Infectiousness E¤ects
Consider now the counterfactual contrast
E[Yi2(0; Yi1(1))  Yi2(0; Yi1(0))]:
This considers what would have happened to person 2 had person 1 been
left unvaccinated but if we had set the infection status of person 1 to the
level it would have been if person 1 was vaccinated; this is Yi2(0; Yi1(1)). The
contrast compares this counterfactual to what would have happened to person
2 had person 1 been left unvaccinated but if we had set the infection status of
person 1 to the level it would have been if person 1 was unvaccinated; this is
Yi2(0; Yi1(0)). For this contrast to be non-zero, Yi1(1) and Yi1(0) would have
to di¤er, i.e. the vaccine for person 1 would have to have an e¤ect on the
infection status of person 1, and that change in infection for person 1 would
have to change the infection status for person 2, even if person 1 had been
left unvaccinated. Essentially, the contrast is non-zero if the vaccine prevents
person 1 from being infected and preventing person 1 from being infected in
turn prevents person 2 from being infected. We thus refer to this counterfactual
contrast as a contagion e¤ect.
As noted in the introduction, vaccinating person 1 may prevent the infec-
tion of person 2 not simply by preventing person 1 from being infected but
also potentially because, even if person 1 is infected, the vaccine may render
the infection less infectious. Consider now the contrast
E[Yi2(1; Yi1(1))  Yi2(0; Yi1(1))]:
This compares what would have happened to person 2 if person 1 had been
vaccinated versus unvaccinated and had person 1 had the infection status that
would have occurred with the vaccine. This contrast will essentially only be
non-zero if person 1 is infected with the vaccine (since person 1s vaccination
status will not a¤ect person 2s outcome unless person 1 is infected). If the
contrast is non-zero then this will be because even when person 1 is vaccinated
and infected, the vaccine itself changes whether person 2 is infected by person
1. This is thus one way to measure what in the infectious disease literature is
referred to as the "infectiousness e¤ect." Other counterfactual formalizations
of the infectiousness e¤ect have also been proposed,3;7 and we will discuss the
relation of these measures to that proposed above at the end of the paper.
These counterfactual denitions of the contagion and infectiousness e¤ects
have the desirable feature that we can decompose an indirect e¤ect into a
contagion and an infectiousness e¤ect essentially by taking the indirect e¤ect
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and adding and subtracting the term E[Yi2(0; Yi1(1)]]:
E[Yi2(1)  Yi2(0)] = E[Yi2(1; Yi1(1))  Yi2(0; Yi1(0))]
= E[Yi2(1; Yi1(1))  Yi2(0; Yi1(1))]
+E[Yi2(0; Yi1(1))  Yi2(0; Yi1(0))]
where the rst term in the sum is the infectiousness e¤ect and the second term
in the sum is the contagion e¤ect. This decomposition is analogous to what in
the mediation analysis literature is sometimes referred to as "natural direct and
indirect e¤ects"12;13. We will in fact be exploiting this analogy in subsequent
sections in our discussion of identication, estimation, and sensitivity analysis.
The term "indirect e¤ect" is used di¤erently in mediation analysis than in
causal inference vaccine literature on interference. In the mediation analysis
literature, "indirect e¤ect" is used to describe the e¤ect of an exposure on
an outcome for one individual that operates through some intermediate or
mediator in that same individual. This is also referred to as a "mediated
e¤ect". In the literature on causal inference in the presence of interference, the
indirect e¤ect of say, vaccinating some persons in a population is a contrast of
potential outcomes comparing the outcomes in those other persons who did not
receive the vaccine to what their outcomes would have been if the vaccinated
persons were not vaccinated. The latter notion of an indirect e¤ect in the
presence of interference is also called a spillover e¤ect in the social science
literature. See the Appendix for further discussion.
Thus far we have been considering measures of e¤ect on a risk di¤erence
scale. However, risk ratio, odds ratio, or vaccine e¢ cacy measures are more
commonly employed in the vaccine literature. The e¤ects described above and
the decomposition described above also have analogues for ratio and vaccine
e¢ cacy measures. For example, the indirect e¤ect on the risk ratio and odds
ratio could be dened respectively as E[Yi2(1)]
E[Yi2(0)]
or E[Yi2(1)]=f1 E[Yi2(1)]g
E[Yi2(0)]=f1 E[Yi2(0)]g . Decom-
positions for the indirect e¤ect into a contagion and infectiousness e¤ect also
hold for the risk ratio or odds ratio. For example, for the risk ratio we have
that:
E[Yi2(1)]
E[Yi2(0)]
=
E[Yi2(1; Yi1(1))]
E[Yi2(0; Yi1(1))]
 E[Yi2(0; Yi1(1))]
E[Yi2(0; Yi1(0))]
:
Here the rst term in the product is the infectiousness e¤ect on the risk ratio
scale and the second term is the contagion e¤ect on the risk ratio scale; the
indirect e¤ect is now the product of the contagion and infectiousness e¤ects
on the risk ratio scale, rather than their sum. A similar decomposition holds
for odds ratio measures.
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Likewise, similar denitions and a somewhat analogous decomposition holds
with a vaccine e¢ cacy measure. As in Halloran and Hudgens3, the vaccine ef-
cacy measure for the indirect e¤ect would be dened as:
V Eindirect = 1  E[Yi2(1)]
E[Yi2(0)]
:
We might likewise dene the vaccine e¢ cacy for the contagion e¤ect and in-
fectiousness e¤ect measures as:
V Econt = 1  E[Yi2(0; Yi1(1))]
E[Yi2(0; Yi1(0))]
V Einf = 1  E[Yi2(1; Yi1(1))]
E[Yi2(0; Yi1(1))]
:
Some algebra gives:
1 E[Yi2(1)]
E[Yi2(0)]
=

1  E[Yi2(0; Yi1(1))]
E[Yi2(0; Yi1(0))]

+
E[Yi2(0; Yi1(1))]
E[Yi2(0; Yi1(0))]

1  E[Yi2(1; Yi1(1))]
E[Yi2(0; Yi1(1))]

and we thus have:
V Eindirect = V Econt +

E[Yi2(0; Yi1(1))]
E[Yi2(0; Yi1(0))]

V Einf :
In words, the vaccine e¢ cacy measure for the indirect e¤ect is the sum of the
vaccine e¢ cacy for the contagion e¤ect and that of the infectiousness e¤ect
where the vaccine e¢ cacy of the infectiousness e¤ect is adjusted by the factor
E[Yi2(0;Yi1(1))]
E[Yi2(0;Yi1(0))]

to account for the fact that when the infectiousness e¤ect op-
erates, the contagion e¤ect has essentially already occurred (the infectiousness
e¤ect makes the infection less infectious but this infectiousness e¤ect will not
operate if the vaccine in fact prevents person 1 from being infected).
We could likewise dene each of these e¤ect measure conditional on co-
variates C. For example, the contagion and infectiousness e¤ects on the risk
ratio scale conditional on covariates C = c would be E[Yi2(0;Yi1(1))jC=c]
E[Yi2(0;Yi1(0))jC=c] and
E[Yi2(1;Yi1(1))jC=c]
E[Yi2(0;Yi1(1))jC=c] respectively.
Identication of Contagion and Infectiousness E¤ects
We have dened the contagion and infectiousness e¤ects in terms of coun-
terfactuals that are not immediately estimable from the data. Although these
e¤ects may be of substantive interest, we cannot estimate them without fur-
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ther assumptions. In the appendix we draw on results from counterfactual
theory to show that the contagion and infectiousness e¤ects as dened above
will be identied under the following four assumptions. We assume that data
is available on some set of baseline covariates C that may be attributes of per-
son 1 or of person 2 or household-level attributes. More rigorous statements
of these assumptions are given in the appendix. We assume that conditional
on the set of covariates C the following assumptions hold:
(i) The e¤ect of person 1s vaccine on person 2s infection status is uncon-
founded.
(ii) The covariates C contain all of the common causes of person 1s infection
status and person 2s infection status so that the e¤ect of person 1s infection
status on person 2s infection status is unconfounded.
(iii) The e¤ect of person 1s vaccine on person 1s infection status is uncon-
founded.
(iv) There is no common cause of person 1s infection status and person 2s
infection status that is itself a¤ected by the vaccine.
Under these four assumptions the contagion and infectiousness e¤ects are
identied from the data. Empirical formulas for identication are given in
the appendix. In the next section we will describe how these e¤ects can be
estimated using statistical models.
We now assess the four assumptions in a bit more detail. If the vaccine of
person 1 is randomized as we have been assuming throughout then assump-
tions (i) and (iii) will hold by randomization. In an observational setting
assumptions (i) and (iii) would only hold if a su¢ ciently rich set of covariates
C were available so that vaccination was e¤ectively randomized within strata
of covariates C.
Assumption (ii) is a strong assumption. Assumption (ii) e¤ectively requires
that within the set of available covariates C we have all variables that are com-
mon causes of person 1s infection status and person 2s infection status. Such
common causes might include for example environmental factors related to the
sanitary, spatial and nutritional characteristics of the household. Assumption
(ii) can perhaps be made more plausible by attempting to control for such
variables, but in general it will not be possible to verify assumption (ii). As-
sumption (iv) by contrast is arguably somewhat weaker: it requires that of
all the common causes of person 1s and person 2s infection status, none of
these common causes are a¤ected by the vaccine itself. Since most of these
common causes are likely to be characteristics of the household environment,
it seems reasonably plausible that such characteristics would not be changed
Hosted by The Berkeley Electronic Press
by the vaccine.
The key to identication of the contagion and infectiousness e¤ects thus
arguably lies with trying to ensure the validity of assumption (ii): trying to
adjust for covariates that may be common causes of person 1s and person 2s
infection status.
Statistical Models to Estimate Contagion and Infectiousness E¤ects
The previous section described the identication assumptions required for
estimating the contagion and infectiousness e¤ects and the appendix gives
nonparametric empirical expressions for these e¤ects. Here we consider the
use of two logistic regression models to estimate these e¤ects when they are in
fact identied.
Suppose that the following two logistic regression models are t to the
observed data, (i) for the probability of infection for person 1 conditional on
person 1s vaccine status a1 and the covariates c and (ii) for the probability of
infection for person 2, conditional on person 1s vaccine status a1, person 1s
infection outcome and the covariates c:
logitfP (Y1 = 1ja1; c)g = 0 + 1a1 + 02c:
logitfP (Y2 = 1ja1; y1; c)g = 0 + 1a1 + 2y1 + 3a1y1 + 04c:
Note that the model for person 2s infection status allows for potential statis-
tical interaction between the e¤ects of the vaccine status of person 1 and the
infection status of person 1. Such interaction would likely be present as the
vaccine status of person 1 is unlikely to have an e¤ect on whether person 2 is
infected unless person 1 is in fact infected.
In the results that follow we will suppose that the infection outcome for
person 2 is su¢ ciently rare so that odds ratios approximate risk ratios and the
logistic link approximates a log link. If the infection outcome for person 2 is
not rare then the results given below will hold if the logistic regression model
for Y2 is instead replaced by a log-linear model but the model for Y1 is kept as
a logistic model. No rare outcome assumption or log-linear model is needed
for Y1.
If the covariates C su¢ ce in satisfying assumptions (i)-(iv) above, and
the models above are correctly specied then, as shown in the appendix, the
contagion e¤ect on the risk ratio scale conditional on the covariates C = c is
given by:
E[Yi2(0; Yi1(1))jc]
E[Yi2(0; Yi1(0))jc] =
(1 + e0+
0
2c)(e0+1+
0
2c+0+2+
0
4c + e0+
0
4c)
(1 + e0+1+
0
2c)(e0+
0
2c+0+2+
0
4c + e0+
0
4c)
(1)
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and the infectiousness e¤ect on the risk ratio scale conditional on the covariates
is given by:
E[Yi2(1; Yi1(1))jc]
E[Yi2(0; Yi1(1))jc] =
e1(1 + e0+1+
0
2c+2+3)
(1 + e0+1+
0
2c+2)
: (2)
These expressions can be obtained directly from the estimates of the logistic
regression parameters and standard errors for these could be obtained using
the delta method. In the appendix we discuss adapting SAS and SPSS macros
for mediation analysis15 to compute these contagion and infectiousness e¤ects
as well as standard errors and condence intervals for these parameters.
Sensitivity Analysis for Contagion and Infectiousness E¤ects
The identication and estimation of the contagion and infectiousness ef-
fects depend critically on assumptions (i)-(iv) above. Unfortunately, these are
fairly strong assumptions, especially assumption (ii) that the set of observed
covariates C contains all common causes of the infection status of person 1 and
person 2. In this section we give a relatively straightforward sensitivity analy-
sis technique that can be employed to assess how sensitive ones estimates and
conclusions are to violations of assumption (ii). The technique assumes that
there is an unmeasured binary confounding variable U that is a common cause
of the infection status of person 1 and person 2, and that assumptions (i)-(iv)
would hold conditional on (C;U) but not on the measured covariates C alone.
The investigator can then specify sensitivity parameters corresponding to (i)
the e¤ect of the unmeasured confounding U on the infection status of person 2
conditional on the vaccine status of person 1, the infection status of person 1,
and the observed covariates C and (ii) the prevalence of U within each stratum
dened by the vaccine status of person 1 and the infection status of person 1,
conditional on the observed covariates C. The technique then uses the esti-
mates obtained by controlling only for observed covariates C along with these
sensitivity parameters to calculate the corrected estimates that would have
been obtained had it been possible to control for the unmeasured confounding
variable U as well. The sensitivity analysis parameters can then be varied
across a range of plausible values to assess how sensitive the conclusions and
estimates are to a potential unmeasured common cause of the infection status
of person 1 and person 2.
The technique assumes that the e¤ect of U on the infection status of person
2 is constant across the vaccine status of person 1 and the infection status of
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person 1 and is given by
 =
P (Y2 = 1ja1; y1; c; U = 1)
P (Y2 = 1ja1; y1; c; U = 0) :
The sensitivity analysis parameter  thus captures the e¤ect of U on the
infection status of person 2. The investigator also species the prevalence of
U in each stratum dened by the vaccine status of person 1 and the infection
status of person 1 conditional on the observed covariates C:
rs = P (U = 1ja1 = r; y1 = s; c):
From these sensitivity analysis parameters the following can be calculated
B0 =
1 + (   1)10
1 + (   1)00
B1 =
1 + (   1)11
1 + (   1)01
B2 =
1 + (   1)01
1 + (   1)00
It follows from derivations in VanderWeele21 that if we let
y1 = 1   log(B0)
y2 = 2   log(B2)
y3 = 3   log(B1) + log(B0)
and replace (1; 2; 3) with (
y
1; 
y
2; 
y
3) in formulas (1) and (2) then this would
give corrected contagion and infectiousness e¤ect estimates corresponding to
what would have been obtained had we been able to adjust for U and C rather
than only the observed covariates C alone. In general we will not know the
true values of the sensitivity analysis parameters; however, by varying the
parameters  and 00; 10; 01; 11 we will be able to have some sense as to
how sensitive the results are to potential unmeasured common causes of the
infection status of person 1 and person 2. The sensitivity technique is of course
also limited by the assumptions made which are (i) a single unmeasured binary
confounder and (ii) that the e¤ect of U on the infection status of person 2 is
constant across the vaccine status of person 1 and the infection status of person
1.
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Illustration
Consider the hypothetical vaccine trial data in Table 1 in which person 1 is
randomized to the vaccine, there are two persons per household, outcome data
is available on both persons, and information is also available on household
level socioeconomic status.
Table 1. Numbers infected, (Yi1; Yi2), from a hypothetical randomized vaccine
trial, by vaccination status (Ai1; Ai2) and socioeconomic status (SES)
Yi1 = 0; Yi2 = 0 Yi1 = 1; Yi2 = 0 Yi1 = 1; Yi2 = 1
Low SES: Ai1 = 0; Ai2 = 0 200 120 180
Low SES: Ai1 = 1; Ai2 = 0 350 96 54
High SES: Ai1 = 0; Ai2 = 0 250 125 125
High SES: Ai1 = 1; Ai2 = 0 400 75 25
If we t a logistic model for the probability of infection for person 1 con-
ditional on person 1s vaccine status a1 and the covariates c and a log-linear
model for the probability of infection for person 2, conditional on person 1s
vaccine status a1, person 1s infection outcome and the covariates c and then
use the expressions (1) and (2) above for the contagion and infectiousness ef-
fects, setting the covariate to its mean value, we obtain, under assumptions
(i)-(iv), an overall estimate of the indirect e¤ect on the risk ratio scale of 0:63
(95% CI: 0:56; 0:70), an estimate of the contagion e¤ect on the risk ratio scale
of 0:80 (95% CI: 0:74; 0:85) and an estimate of the infectiousness e¤ect on the
risk ratio scale of 0:79 (95% CI: 0:71; 0:87). The indirect e¤ect on the risk
ratio scale decomposes into the product of the contagion and infectiousness
e¤ects: 0:63 = 0:80  0:79. On the vaccine e¢ cacy scale, we would have an
overall indirect e¤ect vaccine e¢ cacy of 1   0:63 = 37%, a contagion e¤ect
vaccine e¢ cacy of 1   0:80 = 20%, an infectiousness e¤ect vaccine e¢ cacy of
1 0:79 = 21%, and vaccine e¢ cacy component due to the infectiousness e¤ect
of (0:80)(21%) = 17% (essentially taking into account the fact that the infec-
tiousness e¤ect will operate only if the contagion e¤ect has not). We can then
decompose the indirect e¤ect vaccine e¢ cacy into the sum of the contagion ef-
fect vaccine e¢ cacy and the vaccine e¢ cacy component due to infectiousness:
37% = 20% + 17%. In this hypothetical example, roughly equal portions of
the indirect e¤ect of person 1s vaccine on person 2s infection status appear
to be due to the contagion e¤ect versus the infectiousness e¤ect.
Discussion
In this paper we have considered how an indirect e¤ect of the vaccine of one
person on the outcome of another can be decomposed into two components:
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one corresponding to the vaccine preventing the infection in person 1 which
then protects person 2 (the contagion e¤ect) and another corresponding to the
fact that even if person 1 is infected the vaccine may render the infection less
infectious (the infectiousness e¤ect). The infectiousness e¤ect has been consid-
ered in other work in the vaccine literature6;22;23 and within causal inference.3;7
Halloran and Hudgens3 and VanderWeele and Tchetgen Tchetgen7 formalize
the infectiousness e¤ect by examining the e¤ect of the vaccine of person 1 on
the infection status of person 2 in the "principal stratum"24 in which person 1
would be infected irrespective of vaccine status. Issues of inference for this "in-
fectiousness e¤ect" are described elsewhere.3;7 This infectiousness e¤ect based
on principal strata is somewhat di¤erent than that considered here: essentially
the "principal stratum" infectiousness e¤ect is a conditional e¤ect (it condi-
tions on the subgroup for which person 1 would be infected irrespective of
vaccine status), whereas as the infectiousness e¤ect considered here is an un-
conditional infectiousness e¤ect - it averages over also those clusters for whom
person 1 is uninfected (for which any potential infectiousness e¤ect of the
vaccine would not have the opportunity to operate). These issues are impor-
tant in the interpretation of these e¤ects; both types of infectiousness e¤ects
(conditional and unconditional) could potentially be reported. The advantage
of the infectiousness e¤ect given in this paper (the unconditional version) is
that it can be used to decompose the overall e¤ect into the contagion and
infectiousness components.
Our work here could be extended in a number of directions and is also sub-
ject to various limitations which could likewise prompt further research on this
topic. First, we have considered the setting in which there are two persons per
cluster and only one person is randomized to vaccination. However, in settings
in which both are randomized to vaccination, the same type of analysis as that
described here could be pursued separately for households in which person 2
is or is not vaccinated. Another simple extension to the work here might in-
volve settings in which only one person in each household is randomized to
the vaccine but outcome data is collected on numerous additional individuals
per household. In such cases the outcome Yi2 in this paper could be replaced
with the proportion in the household who are infected (other than the person
randomized); the logistic regression would then have to be replaced with a
linear or log-linear regression but similar methods from the mediation analysis
literature could potentially be adapted and applied.15 If the numbers in each
household vary across households, this number could also be controlled for in
the analysis. The approach described here could perhaps be further extended
to other settings, possible including the use of network data. One limitation of
the approach described here is that the analysis assumed that the regression
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models were correctly specied. In settings with a large number of covari-
ates this may be a di¢ cult assumption to make plausible. Future research
could consider adapting robust statistical methods from the mediation analy-
sis literature25 to help deal with this issue of model specication. Another
limitation is that we have assumed that only person 1, not person 2, can be
infected from outside of the household. While this may be plausible if person 2
is elderly or an infant (or perhaps in certain case-control study designs for rare
infections), in many other settings the assumption will not be plausible. How-
ever, once this assumption is relaxed so that person 2 can be infected outside
the household then it will be possible for person 2 to infect person 1 and then
the temporal ordering between the infection status of person 1 and person 2
is no longer clear, rendering it di¢ cult to utilize the methodology employed
here. Future research could consider extending the current methodology to
settings in which both persons can be infected outside the household by using
data on the timing of infections.3
Halloran5 proposed the minicommunity design to estimate indirect e¤ects
of vaccination. In the minicommunity design, the household or other small
transmission unit serves as the cluster in which to estimate indirect e¤ects
of vaccination, similar to studies in larger communities to estimate indirect,
total, and overall e¤ects. In some individually randomized, controlled vaccine
trials, it may be straightforward to enroll households of trial participants for
follow up; (see Trollfors et al.26 for an example. A similar suggestion, called
the augmented study design, was made by Longini et al.27 and Datta et al.28 to
estimate vaccine e¢ cacy for infectiousness in HIV vaccine trials. Such studies
would be relatively cost-e¤ective to conduct. Because establishing that vac-
cination can have indirect e¤ects and estimating the e¤ects of vaccination on
reducing infectiousness for others could have important implications for global
vaccine policy, it is important to consider collecting outcome data on other
household members in vaccine trials. Such studies would allow estimation of
the indirect, contagiousness and infectiousness e¤ects described in this paper.
Appendix
Formalizations and Derivations
In this appendix we give a formal statement of the identication assump-
tion (i)-(iv) in the text, provide non-parametric empirical expressions for the
contagion and infectiousness e¤ects when they are identied, derive closed form
expressions for these when logistic or log-linear regression models are used to
model the probabilities of infection and provide a sensitivity analysis technique
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when the identication assumptions are violated. Most of this is accomplished
by noting an analytic relation between the contagion and infectiousness e¤ects
dened in the text and what are sometimes called "natural direct and indirect
e¤ects" in the literature on mediation12 15;21. Within the mediation analysis
literature, the interest lies in assessing the extent to which the e¤ect of an
exposure A on outcome Y is mediated by some intermediateM . Essentially if
within the mediation context, we take the exposure as person 1s vaccine sta-
tus, the mediator as person 1s infection status, and the outcome as person 2s
infection status, then the contagion and infectiousness e¤ects dened in this
paper correspond to the "total" natural direct e¤ect and the "pure" natural
indirect e¤ect respectively in the mediation analysis literature.12;14;29
We rst formalize identication assumptions (i)-(iv) above. We use X ?
? Y jZ to denote that X is conditionally independent of Y given Z. In coun-
terfactual notation, assumptions (i)-(iv) in the text can be formally stated
as:
(i) Yi2(ai1; yi1) ?? Ai1jC
(ii) Yi2(ai1; yi1) ?? Yi1j(C;Ai1)
(iii) Yi1(ai1) ?? Ai1jC
(iv) Yi2(ai1; yi1) ?? Yi1(a0i1)jC
Drawing on the analogy with the mediation analysis literature, the inter-
pretation of (i)-(iv) above is essentially that13;14:
(i) The e¤ect of Ai1 on Yi2 is unconfounded conditional on C
(ii) The e¤ect of Yi1 on Yi2 is unconfounded conditional on (C;Ai1)
(iii) The e¤ect of Ai1 on Yi1 is unconfounded conditional on C
(iv) Given that (ii) holds, there is no confounder of the relationship between
Yi1 and Yi2 that is itself a¤ected by Ai1
Assumptions (i) and (iii) will hold if Ai1, the vaccine status of person 1,
is randomized. Assumptions (ii) and (iv) are substantial and would have be
to determined on subject matter grounds. Under assumptions (i)-(iv), the
contagion and infectiousness e¤ects are identied from the vaccine trial data.
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To see this, note that:
E[Yi2(ai1; Yi1(a
0
i1))jc] =
X
y1
E[Yi2(ai1; y1)jYi1(a0i1) = y1; c]P (Yi1(a0i1) = y1jc)
=
X
y1
E[Yi2(ai1; y1)jc]P (Yi1(a0i1) = y1jc)
=
X
y1
E[Yi2(ai1; y1)jai1; c]P (Yi1(a0i1) = y1ja0i1; c)
=
X
y1
E[Yi2(ai1; y1)jai1; y1; c]P (Yi1(a0i1) = y1ja0i1; c)
=
X
y1
E[Yi2jai1; y1; c]P (Yi1 = y1ja0i1; c)
where the rst equality holds by iterated expectations, the second by assump-
tion (iv), the third by assumptions (i) and (iii), the fourth by assumption (ii)
and the nal equality holds by what is sometimes referred to as "consistency".
The nal expression is given in terms of the observed data. If we rst let
ai1 = 0; a
0
i1 = 1 and then ai1 = 0; a
0
i1 = 0, we obtain that the contagion e¤ect
conditional on C is given by E[Yi2(0; Yi1(1))  Yi2(0; Yi1(0))jc] =
X
y1
E[Yi2jAi1 = 0; y1; c]fP (Yi1 = y1jAi1 = 1; c)  P (Yi1 = y1jAi1 = 0; c)g:
If we rst let ai1 = 1; a0i1 = 1 and then ai1 = 0; a
0
i1 = 1, we obtain that the
infectiousness e¤ect is given by E[Yi2(1; Yi1(1))  Yi2(0; Yi1(1)jc] =X
y1
fE[Yi2jAi1 = 1; y1; c]  E[Yi2jAi1 = 0; y1; c]gP (Yi1 = y1jAi1 = 1; c):
The contagion e¤ect then essentially contrasts the observed expectation
E[Yi2jAi1 = 0; y1; c] as standardized by the distribution of the infection status
of person 1 among the households with person 1 vaccinated versus unvacci-
nated. The infectiousness e¤ect then e¤ectively is the observed expectation
contrast E[Yi2jAi1 = 1; y1; c]  E[Yi2jAi1 = 0; y1; c] standardized by the distri-
bution of the infection status of person 1 among the households with person
1 vaccinated.
Likewise on a risk ratio scale we have that the contagion e¤ect is given by:
E[Yi2(0; Yi1(1))jc]
E[Yi2(0; Yi1(0))jc] =
X
y1
E[Yi2jAi1 = 0; y1; c]P (Yi1 = y1jAi1 = 1; c)X
y1
E[Yi2jAi1 = 0; y1; c]P (Yi1 = y1jAi1 = 0; c)
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and the infectiousness e¤ect is given by:
E[Yi2(1; Yi1(1))jc]
E[Yi2(0; Yi1(1))jc] =
X
y1
E[Yi2jAi1 = 1; y1; c]P (Yi1 = y1jAi1 = 1; c)X
y1
E[Yi2jAi1 = 0; y1; c]P (Yi1 = y1jAi1 = 1; c)
:
Suppose now that the following two models were t to the data:
log itfP (Y1 = 1ja1; c)g = 0 + 1a1 + 02c:
log itfP (Y2 = 1ja1; y1; c)g = 0 + 1a1 + 2y1 + 3a1y1 + 04c
and that the infection outcome Y2 for person 2 is su¢ ciently rare so that odds
ratios approximated risk ratios (and the logit link approximated a log-link).
Using these models for the conditional predicted probabilities for Y1 and Y2
gives, for the contagion e¤ect:
E[Yi2(0; Yi1(1))jc]
E[Yi2(0; Yi1(0))jc] =
X
y1
E[Yi2jAi1 = 0; y1; c]P (Yi1 = y1jAi1 = 1; c)X
y1
E[Yi2jAi1 = 0; y1; c]P (Yi1 = y1jAi1 = 0; c)

e0+2+
0
4c e
0+1+
0
2c
1+e0+1+
0
2c
+ e0+
0
4c 1
1+e0+1+
0
2c
e0+2+
0
4c e
0+
0
2c
1+e0+
0
2c
+ e0+
0
4c 1
e0+
0
2c
=
(1 + e0+
0
2c)(e0+1+
0
2c+0+2+
0
4c + e0+
0
4c)
(1 + e0+1+
0
2c)(e0+
0
2c+0+2+
0
4c + e0+
0
4c)
and for the infectiousness e¤ect:
E[Yi2(1; Yi1(1))jc]
E[Yi2(0; Yi1(1))jc] =
X
y1
E[Yi2jAi1 = 1; y1; c]P (Yi1 = y1jAi1 = 1; c)X
y1
E[Yi2jAi1 = 0; y1; c]P (Yi1 = y1jAi1 = 1; c)

e0+1+2+3+
0
4c e
0+1+
0
2c
1+e0+1+
0
2c
+ e0+1+
0
4c 1
1+e0+1+
0
2c
e0+2+
0
4c e
0+1+
0
2c
1+e0+1+
0
2c
+ e0+
0
4c 1
1+e0+1+
0
2c
=
e1(1 + e0+1+
0
2c+2+3)
(1 + e0+1+
0
2c+2)
:
If the infection outcome for person 2 is not rare then the results above will
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hold if the logistic regression model for Y2 is replaced by a log-linear model
but the model for Y1 is kept as a logistic model. No rare outcome assumption
or log-linear model is needed for Y1. Standard errors and condence intervals
for these expressions can be obtained via the delta method as in Valeri and
VanderWeele.15 In fact, the SAS and SPSS macros in Valeri and VanderWeele15
can be directly adapted to estimate these e¤ects and their standard errors and
condence intervals by: specifying the exposure as the vaccine status of person
1, the mediator as the infection status of person 1, the outcome as the infection
status of person 2, the outcome model as logistic (or log-linear if the infection
outcome for person 2 is not rare), the mediator model as logistic and requesting
the option that the full output be given. The estimates reported for the "pure
natural indirect e¤ect" can then be taken as a measure of the contagion e¤ect
on the conditional risk ratio scale and that reported for the "total natural
direct e¤ect" can be taken as the measure of the infectiousness e¤ect on the
conditional risk ratio scale. The macro provides standard errors and condence
intervals for these estimates. The formal analytic relation between natural
direct and indirect e¤ects and the contagion and infectiousness e¤ects also
allows us to adapt sensitivity analysis techniques for natural direct and indirect
e¤ects21 to apply to contagion and infectiousness e¤ects as in the text.
A few further technical comments merit attention. VanderWeele and Tch-
etgen Tchetgen7 provided an alternative denition of the infectiousness e¤ect
on a ratio scale asE[Yi2(1; Yi1(1))jYi1(1) = Yi1(0) = 1]=E[Yi2(0; Yi1(0))jYi1(1) =
Yi1(0) = 1] i.e. the e¤ect of the vaccine of person 1 on the infection status
of person 2 in the "principal stratum"24 in which person 1 would be infected
irrespective of vaccine status. This infectiousness e¤ect is "conditional" in
the sense that it is conditional on the subgroup for which person 1 would
be infected irrespective of vaccine status, whereas the infectiousness e¤ect in
the text is an unconditional infectiousness e¤ect - it averages over also those
households for whom person 1 is uninfected. Yet another denition of an in-
fectiousness e¤ect could be given as E[Yi2(1; 1)jc]=E[Yi2(0; 1)jc] i.e. the e¤ect
of the vaccine of person 1 on the outcome of person 2, intervening to set person
1s infection status to present. This e¤ect is analogous to the "controlled direct
e¤ect"12;13 in the mediation literature. Under assumptions (i) and (ii) above
it is identied by E[Yi2jAi1 = 1; Yi1 = 1; C = c]=E[Yi2jAi1 = 0; Yi1 = 1; C = c].
It is a marginal e¤ect insofar as it is for the entire population for which C = c;
however it is "conditional on infection" in the sense that it considers a hypo-
thetical contrast in which, in all households, person 1 is infected. Under the
logistic regression models given above (assuming rare outcome or using a log-
linear model rather than logistic model for Yi2), this would be e1+3. It should
also be noted that under the exclusion restriction that the vaccine of person
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1 does not a¤ect the infection status of person 2 unless person 1 is infected
we would have E[Yi2(1; 0)jc]=E[Yi2(0; 0)jc] = 1. Under assumptions (i) and (ii)
and the two regression models we then have 1 = E[Yi2(1; 0)jc]=E[Yi2(0; 0)jc] =
E[Yi2jAi1 = 1; Yi1 = 0; C = c]=E[Yi2jAi1 = 0; Yi1 = 0; C = c] = e1 i.e. 1 = 0.
This implication of the exclusion restriction can be tested empirically.
A Note on Terminology
In this paper we have exploited relations between what we have dened as
the "contagion and infectiousness e¤ects" on the one hand and "natural di-
rect and indirect e¤ects" on the other. Because of the terminological overlap,
the language employed can be somewhat confusing. In the mediation analysis
literature13, "indirect e¤ect" is used to describe situations in which the e¤ect
of an exposure on an outcome for one person operates through some intermedi-
ate or mediator for that individual. The "contagion e¤ect" and "infectiousness
e¤ect" in this paper are, analytically somewhat analogous to the "natural indi-
rect e¤ect" and "natural direct e¤ect", respectively, in the mediation analysis
literature. The "contagion e¤ect" is essentially the e¤ect of person 1s vaccine
on person 2s infection outcome mediated by person 1s infection outcome.
The "infectiousness e¤ect" is essentially the e¤ect of person 1s vaccine on
person 2s infection outcome not mediated by person 1s infection outcome.
In the infectious disease and vaccine literature, the "indirect e¤ect of vac-
cination" has one more general usage and also a more technical meaning.1 In
general, an "indirect e¤ect of vaccination" is used to describe settings in which
vaccination of one person a¤ects the outcome of another individual. This is
a specic case of the dependent happenings described by Sir Ronald Ross30
wherein the number of events depends on howmany others are already a¤ected.
However, in the causal inference literature for vaccine e¤ects, there are several
e¤ects of vaccination strategies due to the interference between individuals2,
wherein the treatment assignment of one person a¤ects the potential outcomes
of other persons.16;19;20 In this literature, the indirect e¤ect of vaccination is
the e¤ect of a vaccination strategy in a population in those individuals, or a
subpopulation of those individuals, who were not vaccinated. The total e¤ect
of vaccination is the e¤ect of a vaccination strategy in a population in those
individuals, or a subpopulation of those individuals, who were vaccinated.
More recent formal papers on these indirect and total e¤ects in the presence
of interference include Hudgens and Halloran10, VanderWeele and Tchetgen
Tchetgen11, and Tchetgen Tchetgen and VanderWeele.4 In other statistical
and causal inference literature the e¤ects due to interference are sometimes
called "spillover e¤ects".17
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In this paper, we have decomposed the "indirect e¤ect of a vaccination" in
the literature on causal inference in the presence of interference into the "nat-
ural indirect e¤ect" and "natural direct e¤ect" of mediation analysis. Because
these two literatures, causal inference in the presence of interference on the
one hand and causal inference mediation analysis on the other hand - use the
same terms for di¤erent concepts, and moreover because, as we have seen in
this paper, these concepts are not entirely unrelated, it is important to clarify
in each instance how specically the various terms are being employed.
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